Table 1: Clinicopathological characteristics of 130 PCa patients treated with radical prostatectomy.

Variables

Total N = 130 (%)

Median age, years (range)

(130) 62.0 (49-77)

cT stage

T1

T2A

T2B

T3

T4

Tx

 

11 (8.5)

14 (10.8)

57 (43.8)

37 (28.5)

10 (7.7)

1 (0.8)

pT stage

pT1

pT2

pT3

pT4

 

12 (9.2)

71 (54.6)

38 (29.2)

9 (6.9)

Histological grade AJCC

1

2-3

4-5

 

69 (53.1)

49 (37.7)

12 (9.2)

Gleason Score

≤ 6

7

≥ 8

 

67 (51.5)

50 (38.5)

13 (10.0)

Radicality of surgery

Yes

No

 

85 (65.4)

45 (34.6)

Hist-pat surgical margins

Negative

Positive

 

71 (54.6)

59 (45.4)

Seminal vesicle(s) invasion

Negative

Positive

 

107 (82.3)

23 (17.7)

Adjuvant treatment

None

Radiotherapy (RT)

Hormontherapy (H)

RT + H

RT + H + chemotherapy (CHT)

antiLH-RHa

LH-RH + RT

 

77 (59.2)

26 (20.0)

11 (8.5)

12 (9.2)

2 (1.5)

1 (0.8)

1 (0.8)

Follow-up time (months)

Median (range)

 

79.0 (1 – 148)

Local recurrences

Median time, months (range)

Metastases

Median time (range)

12 (9.2)

29 (5-92)

13 (10.0)

46 (11-88)

aLuteinizing hormone-releasing hormone.